The multicenter clinical test which considers predictive risk factors of acute kidney injury after chemotherapy including cisplatinu
Not Applicable
- Conditions
- rothelial cancer
- Registration Number
- JPRN-UMIN000023553
- Lead Sponsor
- Teikyo Universith School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
patient with maintenance HD therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the presence or absence of AKI after CDDP chemotherapy
- Secondary Outcome Measures
Name Time Method the predictive risk factors of AKI after chemotherapy including CDDP